Capecitabine and streptozocin ± cisplatin for gastroenteropancreatic neuroendocrine tumours: predictors of long-term survival in the NET01 trial
Main Authors: | , , , , , , , , , , , , , , , , |
---|---|
פורמט: | Conference item |
יצא לאור: |
Oxford University Press
2016
|